Kiniksa Pharmaceuticals International Plc (KNSA)
77.09
-0.82
(-1.05%)
USD |
NASDAQ |
Sep 08, 16:00
80.00
+2.91
(+3.77%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Market Cap : 6.011B for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 6.011B |
| September 04, 2026 | 6.075B |
| September 03, 2026 | 6.275B |
| September 02, 2026 | 6.230B |
| September 01, 2026 | 6.182B |
| August 31, 2026 | 6.132B |
| August 28, 2026 | 6.089B |
| August 27, 2026 | 6.223B |
| August 26, 2026 | 6.135B |
| August 25, 2026 | 6.254B |
| August 24, 2026 | 6.190B |
| August 21, 2026 | 6.163B |
| August 20, 2026 | 6.119B |
| August 19, 2026 | 6.301B |
| August 18, 2026 | 6.199B |
| August 17, 2026 | 6.174B |
| August 14, 2026 | 5.985B |
| August 13, 2026 | 6.069B |
| August 12, 2026 | 6.094B |
| August 11, 2026 | 6.067B |
| August 10, 2026 | 5.968B |
| August 07, 2026 | 5.931B |
| August 06, 2026 | 5.966B |
| August 05, 2026 | 6.089B |
| August 04, 2026 | 5.926B |
| Date | Value |
|---|---|
| August 03, 2026 | 5.724B |
| July 31, 2026 | 5.797B |
| July 30, 2026 | 6.098B |
| July 29, 2026 | 6.310B |
| July 28, 2026 | 6.195B |
| July 27, 2026 | 4.954B |
| July 24, 2026 | 4.900B |
| July 23, 2026 | 4.835B |
| July 22, 2026 | 4.788B |
| July 21, 2026 | 4.874B |
| July 20, 2026 | 4.799B |
| July 17, 2026 | 4.904B |
| July 16, 2026 | 4.686B |
| July 15, 2026 | 4.731B |
| July 14, 2026 | 4.753B |
| July 13, 2026 | 4.673B |
| July 10, 2026 | 4.865B |
| July 09, 2026 | 5.014B |
| July 08, 2026 | 4.966B |
| July 07, 2026 | 5.160B |
| July 06, 2026 | 4.814B |
| July 02, 2026 | 4.949B |
| July 01, 2026 | 4.823B |
| June 30, 2026 | 4.904B |
| June 29, 2026 | 4.786B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Autolus Therapeutics Plc | 561.60M |
| Barinthus Biotherapeutics Plc | 30.23M |
| Scancell Holdings Plc | 145.29M |
| OptiBiotix Health Plc | 11.36M |
| Immunocore Holdings Plc | 1.820B |
Market Cap Related Metrics
| PE Ratio | 78.38 |
| PS Ratio | 7.504 |
| PEG Ratio | 0.0341 |
| Price to Book Value | 9.190 |
| Price to Free Cash Flow | 34.51 |
| Price | 77.09 |
| Earnings Yield | 1.28% |
| PEGY Ratio | 0.0341 |
| Operating PE Ratio | 62.94 |
| Normalized PE Ratio | 78.38 |